Clinical characteristics of stroke in SARS-CoV-2 infected patients in Japan: A prospective nationwide study

Yasuhiro Nishiyama(Nippon Medical School Hospital), Kazumi Kimura(Nippon Medical School), Kensaku Yoshida(Tokyo Metropolitan Hiroo Hospital), Masatoshi Koga(National Cerebral and Cardiovascular Center), Nobuyuki Sakai(Shizuoka City Shimizu Hospital), Manabu Sakaguchi(Osaka Prefectural Medical Center), Susumu Miyamoto(Kyoto University Hospital), Hiroshi Yamagami(Osaka City University), Shunsuke Ichi(Japanese Red Cross Medical Center), Naoki Tokuda(Kyoto first Red Cross hospital), Teruyuki Hirano(The Graduate University for Advanced Studies, SOKENDAI), Ikuya Yamaura, Yasuyuki Iguchi(Jikei University School of Medicine)
Journal of the Neurological Sciences
January 4, 2024
10.1016/j.jns.2023.122865
Cited by 2

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
|Circulation|1981|250
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
|New England Journal of Medicine|2023|217
C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis
|Circulation|2001|216
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
|The Lancet Neurology|2019|216